🇺🇸 FDA

Intelligence · Clinical Pipeline

BRIGHT MINDS BIOSCIENCES Pipeline

All ClinicalTrials.gov programs at BRIGHT MINDS BIOSCIENCES — phase, modality, and trial IDs.

Programs
1,063

Quick answer

BRIGHT MINDS BIOSCIENCES has 1,063 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Treatment as usual (TAU)

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Abuse

    phase 1 other completed

    1 trial

  2. UB-312

    BRIGHT MINDS BIOSCIENCES INC.

    Parkinson's Disease

    phase 1 mab completed

    1 trial

  3. VK4-116

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Dependence

    phase 1 small molecule active

    1 trial

  4. Vaporized Marijuana

    BRIGHT MINDS BIOSCIENCES INC.

    Marijuana Usage

    phase 1 small molecule completed

    1 trial

  5. Varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Addiction

    phase 1 small molecule terminated

    1 trial

  6. Varenicline Tartrate

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Addiction

    phase 1 small molecule active

    1 trial

  7. Varenicline, then placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine Addiction

    phase 1 small molecule completed

    1 trial

  8. Vicks VapoInhaler

    BRIGHT MINDS BIOSCIENCES INC.

    Opiates

    phase 1 small molecule completed

    1 trial

  9. Viewing e-cigarette ads

    BRIGHT MINDS BIOSCIENCES INC.

    E-Cig Use

    phase 1 other completed

    1 trial

  10. Woebot Substance Use Disorder

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Use Disorders

    phase 1 other completed

    1 trial

  11. Woman-focused intervention

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    phase 1 other completed

    1 trial

  12. XR-NTX community location

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Dependence

    phase 1 small molecule completed

    1 trial

  13. YB-1113

    BRIGHT MINDS BIOSCIENCES INC.

    POI

    phase 1 small molecule active

    1 trial

  14. Yohimbine Hydrochloride

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoking

    phase 1 small molecule completed

    1 trial

  15. Zolmitriptan intranasal.

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    phase 1 small molecule completed

    1 trial

  16. [11C]APP311

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Use Disorder

    phase 1 small molecule active

    1 trial

  17. [11C]OMAR

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Control

    phase 1 small molecule active

    1 trial

  18. [18F]fluoro-PEG-folate PET/CT scan

    BRIGHT MINDS BIOSCIENCES INC.

    Epithelial Ovarian Cancer

    phase 1 other terminated

    1 trial

  19. [F18]-ASEM (3-(1,4-diazabicyclo[3.2.2]nonan-4-yl)-6-[18F]fluorodibenzo[b,d]thiophene 5,5-dioxide)

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 1 small molecule completed

    1 trial

  20. buprenorphine

    BRIGHT MINDS BIOSCIENCES INC.

    Neonatal Abstinence Syndrome

    phase 1 small molecule completed

    1 trial

  21. cannabis

    BRIGHT MINDS BIOSCIENCES INC.

    Behavioral Pharmacology of Cannabis

    phase 1 small molecule completed

    1 trial

  22. cimetidine (or acyclovir)

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    phase 1 small molecule completed

    1 trial

  23. ciprofloxacin

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    phase 1 small molecule completed

    1 trial

  24. cocaine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Use

    phase 1 small molecule completed

    1 trial

  25. cocaine hydrochloride

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 1 small molecule completed

    1 trial

  26. d-amphetamine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 1 small molecule completed

    1 trial

  27. d-amphetamine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    phase 1 small molecule completed

    1 trial

  28. d-amphetamine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Use Disorder

    phase 1 small molecule active

    1 trial

  29. delta 9 tetrahydrocannabinol

    BRIGHT MINDS BIOSCIENCES INC.

    COMT Gene Polymorphism

    phase 1 small molecule completed

    1 trial

  30. drug condition

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis

    phase 1 small molecule completed

    1 trial

  31. eszopiclone

    BRIGHT MINDS BIOSCIENCES INC.

    Marijuana Dependence

    phase 1 small molecule completed

    1 trial

  32. iTBS to the left dlPFC

    BRIGHT MINDS BIOSCIENCES INC.

    Chronic Pain

    phase 1 other completed

    1 trial

  33. l-THP (l-tetrahydropalmatine)

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Use

    phase 1 small molecule completed

    1 trial

  34. lofexidine HCl

    BRIGHT MINDS BIOSCIENCES INC.

    Renally Impaired Subjects

    phase 1 small molecule completed

    1 trial

  35. mHealth application (custom)

    BRIGHT MINDS BIOSCIENCES INC.

    Cognitive Function Abnormal

    phase 1 other completed

    1 trial

  36. metyrapone & oxazepam

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Use Disorder

    phase 1 small molecule completed

    1 trial

  37. mitragynine

    BRIGHT MINDS BIOSCIENCES INC.

    Safety and Tolerability in Healthy Subjects

    phase 1 small molecule active

    1 trial

  38. oral naltrexone

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Dependence

    phase 1 small molecule completed

    1 trial

  39. quitSTART Mobile Application

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Vaping

    phase 1 other active

    1 trial

  40. radioactive substance

    BRIGHT MINDS BIOSCIENCES INC.

    Amphetamine-Related Disorders

    phase 1 other active

    1 trial

  41. routine HIV testing

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    phase 1 other completed

    1 trial

  42. standard care

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    phase 1 other terminated

    1 trial

  43. veliparib

    BRIGHT MINDS BIOSCIENCES INC.

    Small Cell Lung Cancer SCLC

    phase 1 small molecule active

    1 trial

  44. 400IU cholecalciferol and 500mg of elemental calcium as calcium carbonate

    BRIGHT MINDS BIOSCIENCES INC.

    Benign Paroxysmal Positional Vertigo

    approved small molecule completed

    1 trial

  45. 99mTc-Macro Albumin Aggregate

    BRIGHT MINDS BIOSCIENCES INC.

    Carcinoma

    approved small molecule completed

    1 trial

  46. Adderall

    BRIGHT MINDS BIOSCIENCES INC.

    Attention Deficit Disorder With Hyperactivity

    approved small molecule completed

    1 trial

  47. Algorithm Treatment

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    approved small molecule completed

    1 trial

  48. Amantadine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    approved small molecule completed

    3 trials

Frequently asked questions

How many pipeline programs does BRIGHT MINDS BIOSCIENCES have?

1,063 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.